Our mission is to deliver impactful medicines and solutions for a healthier every day.
Our portfolio encompasses more than 60 medicines and devices across a range of areas including reproductive health, cardiovascular disease, neurology, autoimmune, and respiratory conditions. We bring these important therapies to more than 150 markets around the world.
Our portfolio in women’s health, biosimilars, and established brands are the foundation for how we strive to achieve our vision to create a better and healthier every day. We work to provide medicines and other products across all of these areas that help address a wide array of conditions and diseases.
We are fearless in our aim to deliver innovation, improve access, and expand choice to help address therapeutic gaps in women’s health.
Through our pipeline and portfolio, we are working to deliver medicines and devices that advance the health of women through all stages of her life journey.
We focus on conditions that are unique to women, affect her disproportionately or impact her differently, including fertility and contraception, maternal health conditions, and vaginal health. Organon’s portfolio and innovation pipeline are focused on these key areas:
We aim to improve health care economies and treatment access by providing high-quality biosimilar medicines to health care systems, providers, and patients.
With insights from our customers, we work to understand the needs of all stakeholders and seek to exceed their expectations.
Helping navigates the complexities of biosimilar adoption is at the core of our commitment to enable the many potential benefits of biosimilars across the health care system. As the biosimilar landscape changes, we adapt—while maintaining an unwavering commitment to patients and providers.
Our approach to biosimilars is focused on providing more accessible treatment options to patients, providers, and healthcare systems. We believe that ethics, empathy, and commitment will ultimately best serve all our stakeholders on the path toward value-driven change.
Our portfolio embodies early innovation and deep heritage and includes medicines that have been helping patients, in some cases for decades.
Providing products across a range of diseases and conditions.
Expanding upon the legacy of these products, we are applying a renewed focus on this portfolio and seizing new opportunities to bring these important treatments to people who need them.
Our established brands span a range of therapeutic areas, including cardiovascular disease, respiratory conditions, dermatology, central nervous system disorders, bone health, immunology, non-opioid pain management, menopause, and more.
